"novel" MAB (alone or in combination) Clinical Trials

1 actively recruiting trial

Top Sponsors

Fondazione Italiana Linfomi - ETS1

Indications

Non-hodgkin Lymphoma,B Cell1
Cancer1

Other1 trial

A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.